Cargando…

N-methyl-2-pyridone-5-carboxamide (2PY)—Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin

N-methyl-2-pyridone-5-carboxamide (2PY, a major metabolite of nicotinamide, NAM) was recently identified as a uremic toxin. Recent interventional trials using NAM to treat high levels of phosphorus in end-stage renal disease have highlighted new potential uremic toxicities of 2PY. In the context of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lenglet, Aurélie, Liabeuf, Sophie, Bodeau, Sandra, Louvet, Loïc, Mary, Aurélien, Boullier, Agnès, Lemaire-Hurtel, Anne Sophie, Jonet, Alexia, Sonnet, Pascal, Kamel, Said, Massy, Ziad A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127135/ https://www.ncbi.nlm.nih.gov/pubmed/27854278 http://dx.doi.org/10.3390/toxins8110339

Ejemplares similares

Uremic Toxins and Vascular Dysfunction
por: Six, Isabelle, et al.
Publicado: (2020)

Association between Uremic Toxin Concentrations and Bone Mineral Density after Kidney Transplantation
por: Batteux, Benjamin, et al.
Publicado: (2020)

Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients
por: Lenglet, Aurélie, et al.
Publicado: (2013)

Potential interactions between uraemic toxins and drugs: an application in kidney transplant recipients treated with calcineurin inhibitors
por: André, Camille, et al.
Publicado: (2021)

Uremic Toxins and Clinical Outcomes: The Impact of Kidney Transplantation
por: Liabeuf, Sophie, et al.
Publicado: (2018)

Protein-Bound Uremic Toxins: New Insight from Clinical Studies
por: Liabeuf, Sophie, et al.
Publicado: (2011)

Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins
por: Laville, Solène M., et al.
Publicado: (2021)

Effect of Sevelamer and Nicotinamide on Albumin Carbamylation in Patients with End-Stage Kidney Disease
por: Lenglet, Aurelie, et al.
Publicado: (2021)

Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase(®))
por: Dernoncourt, Amandine, et al.
Publicado: (2022)

Does P-Cresylglucuronide Have the Same Impact on Mortality as Other Protein-Bound Uremic Toxins?
por: Liabeuf, Sophie, et al.
Publicado: (2013)

Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?
por: El Chamieh, Carolla, et al.
Publicado: (2022)

The Biochemical Pathways of Nicotinamide-Derived Pyridones
por: Hayat, Faisal, et al.
Publicado: (2021)

An unusual nicotinamide derivative, 4-pyridone-3-carboxamide ribonucleoside (4PYR), is a novel endothelial toxin and oncometabolite
por: Mierzejewska, Paulina, et al.
Publicado: (2021)

The Prescription of Drugs That Inhibit Organic Anion Transporters 1 or 3 Is Associated with the Plasma Accumulation of Uremic Toxins in Kidney Transplant Recipients
por: André, Camille, et al.
Publicado: (2021)

Estimated Glomerular Filtration Rate Is a Poor Predictor of the Concentration of Middle Molecular Weight Uremic Solutes in Chronic Kidney Disease
por: Neirynck, Nathalie, et al.
Publicado: (2012)

4-Pyridone-3-carboxamide-1-β-D-ribonucleoside Triphosphate (4PyTP), a Novel NAD(+) Metabolite Accumulating in Erythrocytes of Uremic Children: A Biomarker for a Toxic NAD(+) Analogue in Other Tissues?
por: Synesiou, Elena, et al.
Publicado: (2011)

The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function
por: Hénaut, Lucie, et al.
Publicado: (2018)

Comparison of homocitrulline and carbamylated albumin as biomarkers of carbamylation reactions in hemodialyzed patients
por: Lenglet, Aurelie, et al.
Publicado: (2023)

From old uraemic toxins to new uraemic toxins: place of ‘omics’
por: Massy, Ziad A, et al.
Publicado: (2018)

Association between Free Light Chain Levels, and Disease Progression and Mortality in Chronic Kidney Disease
por: Desjardins, Lucie, et al.
Publicado: (2013)

Does kidney transplantation influence a form of discrimination for antihypertensive drugs prescriptions?
por: Cheddani, Lynda, et al.
Publicado: (2021)

Effects of Chronic Kidney Disease and Uremic Toxins on Extracellular Vesicle Biology
por: Yaker, Linda, et al.
Publicado: (2020)

Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients
por: Mary, Aurélien, et al.
Publicado: (2017)

The AKI-to-CKD Transition: The Role of Uremic Toxins
por: André, Camille, et al.
Publicado: (2023)

The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders
por: Assem, Maryam, et al.
Publicado: (2018)

The clinical impact of plasma leptin levels in a cohort of chronic kidney disease patients
por: de Oliveira, Rodrigo Bueno, et al.
Publicado: (2013)

The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial
por: Bennis, Youssef, et al.
Publicado: (2019)

Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease
por: El Chamieh, Carolla, et al.
Publicado: (2023)

Differences in anti-malarial activity of 4-aminoalcohol quinoline enantiomers and investigation of the presumed underlying mechanism of action
por: Mullié, Catherine, et al.
Publicado: (2012)

Total calcium-sensing receptor expression in circulating monocytes is increased in rheumatoid arthritis patients with severe coronary artery calcification
por: Paccou, Julien, et al.
Publicado: (2014)

Urinary Excretion of N(1)-Methylnicotinamide and N(1)-Methyl-2-Pyridone-5-Carboxamide and Mortality in Kidney Transplant Recipients
por: Deen, Carolien P.J., et al.
Publicado: (2020)

Urinary Excretion of N(1)-methyl-2-pyridone-5-carboxamide and N(1)-methylnicotinamide in Renal Transplant Recipients and Donors
por: Deen, Carolien P. J., et al.
Publicado: (2020)

Cellular and molecular mechanisms associated with ischemic stroke severity in female mice with chronic kidney disease
por: Hénaut, Lucie, et al.
Publicado: (2019)

Salivary N1-Methyl-2-Pyridone-5-Carboxamide, a Biomarker for Uranium Uptake, in Kuwaiti Children Exhibiting Exceptional Weight Gain
por: Goodson, Jo Max, et al.
Publicado: (2019)

Inhibition of protein synthesis by N-methyl-2-pyridone-5-formamidoacetic acid and other compounds isolated from uremic patients.
por: Clayton, E. M., et al.
Publicado: (1965)

Synthesis of 4-Pyridone-3-sulfate and an improved synthesis of 3-Hydroxy-4-Pyridone
por: Behrman, Edward J
Publicado: (2009)

The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease
por: Liabeuf, Sophie, et al.
Publicado: (2015)

5-Methyl-2-pyridone
por: Mao, Shulin, et al.
Publicado: (2011)

2-Pyridone: monoclinic polymorph
por: Arman, Hadi D., et al.
Publicado: (2009)

Reduced levels of N’-methyl-2-pyridone-5-carboxamide and lysophosphatidylcholine 16:0 in the serum of patients with intrahepatic cholangiocarcinoma, and the correlation with recurrence-free survival
por: Kim, Kyung-Hee, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ogl7u3am4qoc55lg00vsh20oq4